STRAGEN NORDIC A/S: Financial statements 2019
CVR: 26717825
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
STRAGEN NORDIC A/S (CVR 26717825) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 7,024,337 and a net result of DKK 1,741,348 compared with DKK 1,883,508 the year before. That is an increase of 28% compared with the year before. Equity in the 2019 report amounted to DKK 7,109,941. The solvency ratio was 31.5%. The company had 6 employees in the financial year.
- Gross Profit
- DKK 7,024,337
- Profit/Loss
- DKK 1,741,348
- Equity
- DKK 7,109,941
- Total Assets
- DKK 22,579,869
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 7M | 1.7M | 7.1M | 6 |
| 2018 | - | 5.5M | 1.9M | 5.4M | - |
| 2017 | - | 4.1M | 497K | 3.5M | - |
| 2016 | - | 4.2M | 702K | 3.3M | - |
| 2015 | - | 3.4M | -261K | 2.6M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
STRAGEN NORDIC A/S has published its annual report for 2018. Gross profit came to DKK 5,489,210, and the net result was DKK 1,883,508.
About STRAGEN NORDIC A/S
STRAGEN NORDIC A/S is a Danish company of the type Aktieselskab based in Slangerup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anne Franch Nyquist-Hansen and Didier Remi Dargent. The board consists of Didier Remi Dargent (chair), Jean-Yves Paul Etienne Desmottes and Ludovic Alonzi. The company is owned by Strategic Generics France. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,246,350 and a net result of DKK 529,103 compared with DKK 2,665,035 the year before. Equity in the 2025 report amounted to DKK 9,440,623.
